Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04984200 · ClinicalTrials.gov registry record
Assessment of EyeArt Performance With Retinal Cameras
A clinical trial, sponsored by Eyenuk.
- Completed
- Registry status
- 246
- Enrollment target
NCT04984200: Completed study, sponsored by Eyenuk.
NCT04984200 is a clinical trial that has completed, run by Eyenuk. The registered enrollment target is 246 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04984200 has completed, sponsored by Eyenuk.
- COMPLETED
- Registry status
- 246 participants
- Enrollment target
Study Summary
The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using retinal cameras and operators.
Primary Outcome
Overall agreement is defined as the fraction of cases where the multiple EyeArt operation results agree with each other.
Interventions
- PROCEDURE Retinal imaging
- DRUG Mydriatic Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2021-07-13 |
| Est. Completion | 2022-08-19 |
What the finished NCT04984200 record still lists
NCT04984200 is an observational study that tracks outcomes without assigning an intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Retinal imaging is the first listed.
NCT04984200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04984200 about?
NCT04984200 is a clinical study titled "Assessment of EyeArt Performance With Retinal Cameras". The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using retinal cameras and operators.
What is the current status of trial NCT04984200?
This trial is currently completed. The enrollment target is 246 participants. The study started on 2021-07-13. Estimated completion is 2022-08-19.
What interventions are being tested in trial NCT04984200?
The interventions under investigation include: Retinal imaging (PROCEDURE), Mydriatic Agent (DRUG).
Who is sponsoring clinical trial NCT04984200?
This trial is sponsored by Eyenuk, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI